Weil advised NEOGEN Corporation, a developer and marketer of comprehensive solutions dedicated to food and animal safety, in its $5.3 billion combination with the Food Safety business of 3M, a provider of testing products used to monitor allergens, pathogens and contaminates in food manufacturing processes, in a Reverse Morris Trust transaction that implied an enterprise value of the combined company of $9.3 billion. The transaction closed on September 01, 2022.

The Weil team that advised NEOGEN Corporation was led by Mergers & Acquisitions partner Michael J. Aiello and included Mergers & Acquisitions partners Eoghan Keenan, Megan Pendleton and Michelle Sargent and Mergers & Acquisitions associates Emily Ross and Victor Wang. The team also included Tax Head Joseph Pari; Tax partners Graham Magill; Executive Compensation & Benefits Head Paul Wessel; Executive Compensation & Benefits partner Aimee Adler; Executive Compensation & Benefits associates Radhika Tahiliani and Ace Szmolyan (Not Yet Admitted in New York); Technology & IP Transactions partners Michael Epstein and Dennis Adams; Technology & IP Transactions/Privacy associates Catherine Kim and Maryann Thompson; Banking & Finance partners Gabriel Gregson and Nitin Konchady; Capital Markets partner Frank Adams; Environmental Head Annemargaret Connolly; Regulatory Transactions counsel John O’Loughlin; Antitrust partner Megan Granger; Antitrust counsel Robert Dahnke; Antitrust associate Elizabeth Ross; and Complex Commercial Litigation associate Fredrick Rhine. The London team included Corporate partner David Avery-Gee; Corporate associate Ada Lam; Employment Litigation counsel Thomas Weatherill and Employment Litigation associate Edward Dickinson.